2 completed, 2 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
Follow Nicardipine: new trials by email Literature Review of Nicardipine trials Research Report on Nicardipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping Nicardipine, Standard of care - Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Completed | BIT Pharma GmbH | 41 | 2020-04-05 | 2023-07-12 |
| Blood Pressure After Endovascular Stroke Therapy-II Nicardipine, Labetalol, Hydralazine - Acute Stroke, Endovascular Thrombectomy | Phase 2 | Completed | University of Cincinnati | 120 | 2020-01-17 | 2023-10-12 |
| Safety Study of Nicardipine to Treat Cerebral Vasospasm Nicardipine hydrochloride, Preservative-free normal saline - Cerebral Vasospasm | Phase 2 | Terminated | University of Florida | 2 | 2013-08-01 | 2014-08-29 |
| NICardipine Neuroprotection in AortiC Surgery (NICNACS) Nicardipine, 0.9% saline - Aortic Aneurysm, Thoracic | Phase 2 | Terminated | Duke University | 7 | 2008-01-01 | 2014-08-01 |
Subarachnoid Hemorrhage (2) · Aortic Aneurysm, Thoracic (1) · Stroke (1) · Vasospasm, Intracranial (1)
BIT Pharma GmbH (1) · Duke University (1) · University of Cincinnati (1) · University of Florida (1)
United States (3) · Austria (1) · Germany (1)
Andy Shaw, M. D. (1) · Eva Mistry, MBBS (1) · Spiros L. Blackburn, MD (1)
PMID 37668620, PMID 39158893, PMID 41583626
2017 (1), K23NS113858 (1)